CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.3005
+0.0005 (0.17%)
Nov 20, 2025, 4:00 PM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $372.76 million as of November 20, 2025. Its market cap has increased by 147.97% in one year.
Market Cap
372.76M
Enterprise Value
390.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.30
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 372.76M, an increase of 6,631.51%. That is a compound annual growth rate of 23.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 372.76M | 176.87% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | 3.21B | 695.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.31M |
| Elite Pharmaceuticals | 605.00M |
| Glass House Brands | 434.20M |
| American Oncology Network | 412.69M |
| Northwest Biotherapeutics | 374.98M |
| Silence Therapeutics | 318.83M |
| Nika Pharmaceuticals | 311.89M |
| Tian'an Technology Group | 273.11M |